NEUROONE MEDICAL TECHNOLOGIES CORPORATION - COMMON

NeuroOne® Reports Second Quarter Fiscal Year 2024 Financial Results and Provides Corporate Update

14 May 2024 16:00:00 By Nasdaq GlobeNewswire

NeuroOne® to Report Second Quarter Fiscal Year 2024 Financial Results and Provide Corporate Update on May 14

10 May 2024 14:43:56 By Nasdaq GlobeNewswire

NeuroOne® CEO Dave Rosa Featured on Bloomberg Technology

10 Apr 2024 09:00:00 By Nasdaq GlobeNewswire

NeuroOne® Announces First Implant of OneRF™ Ablation Electrodes

09 Apr 2024 09:05:00 By Nasdaq GlobeNewswire

NeuroOne® CEO Dave Rosa Featured on Fox Business Network’s Varney & Co.

04 Apr 2024 09:00:00 By Nasdaq GlobeNewswire

NeuroOne® Initiates Limited Commercial Launch of OneRF™ Ablation System

26 Mar 2024 09:00:00 By Nasdaq GlobeNewswire

NeuroOne® to Participate in the 36th Annual Roth Conference

08 Mar 2024 12:00:00 By Nasdaq GlobeNewswire

NeuroOne Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

23 Feb 2024 17:10:00 By Nasdaq GlobeNewswire

NeuroOne® Reports First Quarter Fiscal Year 2024 Financial Results and Provides Corporate Update

13 Feb 2024 16:00:00 By Nasdaq GlobeNewswire

NeuroOne® to Report First Quarter Fiscal Year 2024 Financial Results and Provide Corporate Update on February 13

08 Feb 2024 15:30:00 By Nasdaq GlobeNewswire

NeuroOne® Reports Fiscal Fourth Quarter and Full Fiscal Year 2023 Financial Results and Provides Corporate Update

14 Dec 2023 16:15:00 By Nasdaq GlobeNewswire

NeuroOne® Receives FDA 510(k) Clearance to Market its OneRF™ Ablation System

11 Dec 2023 08:00:00 By Nasdaq GlobeNewswire

NeuroOne® to Report Fourth Quarter and Fiscal Year 2023 Financial Results and Provide Corporate Update on December 14

07 Dec 2023 16:30:00 By Nasdaq GlobeNewswire

NeuroOne® Announces Patent Allowance for Drug Delivery Utilizing a Novel Neural Probe

16 Nov 2023 08:00:00 By Nasdaq GlobeNewswire

NeuroOne® Appoints Medtech Executive Christopher R. Volker as Chief Operating Officer and Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

14 Nov 2023 17:15:00 By Nasdaq GlobeNewswire

NeuroOne® Provides Progress Update on FDA 510(k) Submission for OneRF™ Ablation System

07 Nov 2023 08:00:01 By Nasdaq GlobeNewswire

NeuroOne® to Present at the ThinkEquity Conference on October 19, 2023

13 Oct 2023 09:30:00 By Nasdaq GlobeNewswire

NeuroOne® to Present at the H.C. Wainwright 25th Annual Global Investment Conference

06 Sep 2023 16:00:00 By Nasdaq GlobeNewswire

NeuroOne® Reports Third Quarter Fiscal Year 2023 Financial Results and Provides Corporate Update

14 Aug 2023 16:00:00 By Nasdaq GlobeNewswire

NeuroOne® to Report Third Quarter Fiscal Year 2023 Financial Results and Provide a Corporate Update on August 14

08 Aug 2023 16:00:00 By Nasdaq GlobeNewswire